Cargando…

A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor

BACKGROUND: Mucins are implicated in survival in various cancers, but there have been no report addressed on survival in appendiceal carcinoma, an uncommon disease with different clinical and pathological features from those of other colon cancers. We aimed to investigate the clinical implications o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibahara, Hiroaki, Higashi, Michiyo, Yokoyama, Seiya, Rousseau, Karine, Kitazono, Iwao, Osako, Masahiko, Shirahama, Hiroshi, Tashiro, Yukie, Kurumiya, Yasuhiro, Narita, Michihiko, Kuze, Shingo, Hasagawa, Hiroshi, Kato, Takehito, Kubota, Hitoshi, Suzuki, Hideaki, Arai, Toshiyuki, Sakai, Yu, Yuasa, Norihiro, Fujino, Masahiko, Kondo, Shinji, Okamoto, Yoshichika, Yamamoto, Tatsuyoshi, Hiromatsu, Takashi, Sasaki, Eiji, Shirai, Kazuhisa, Kawai, Satoru, Hattori, Koutarou, Tsuji, Hideki, Okochi, Osamu, Sakamoto, Masaki, Kondo, Akinobu, Konishi, Naomi, Batra, Surinder K., Yonezawa, Suguru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281150/
https://www.ncbi.nlm.nih.gov/pubmed/25551773
http://dx.doi.org/10.1371/journal.pone.0115613
_version_ 1782350949263605760
author Shibahara, Hiroaki
Higashi, Michiyo
Yokoyama, Seiya
Rousseau, Karine
Kitazono, Iwao
Osako, Masahiko
Shirahama, Hiroshi
Tashiro, Yukie
Kurumiya, Yasuhiro
Narita, Michihiko
Kuze, Shingo
Hasagawa, Hiroshi
Kato, Takehito
Kubota, Hitoshi
Suzuki, Hideaki
Arai, Toshiyuki
Sakai, Yu
Yuasa, Norihiro
Fujino, Masahiko
Kondo, Shinji
Okamoto, Yoshichika
Yamamoto, Tatsuyoshi
Hiromatsu, Takashi
Sasaki, Eiji
Shirai, Kazuhisa
Kawai, Satoru
Hattori, Koutarou
Tsuji, Hideki
Okochi, Osamu
Sakamoto, Masaki
Kondo, Akinobu
Konishi, Naomi
Batra, Surinder K.
Yonezawa, Suguru
author_facet Shibahara, Hiroaki
Higashi, Michiyo
Yokoyama, Seiya
Rousseau, Karine
Kitazono, Iwao
Osako, Masahiko
Shirahama, Hiroshi
Tashiro, Yukie
Kurumiya, Yasuhiro
Narita, Michihiko
Kuze, Shingo
Hasagawa, Hiroshi
Kato, Takehito
Kubota, Hitoshi
Suzuki, Hideaki
Arai, Toshiyuki
Sakai, Yu
Yuasa, Norihiro
Fujino, Masahiko
Kondo, Shinji
Okamoto, Yoshichika
Yamamoto, Tatsuyoshi
Hiromatsu, Takashi
Sasaki, Eiji
Shirai, Kazuhisa
Kawai, Satoru
Hattori, Koutarou
Tsuji, Hideki
Okochi, Osamu
Sakamoto, Masaki
Kondo, Akinobu
Konishi, Naomi
Batra, Surinder K.
Yonezawa, Suguru
author_sort Shibahara, Hiroaki
collection PubMed
description BACKGROUND: Mucins are implicated in survival in various cancers, but there have been no report addressed on survival in appendiceal carcinoma, an uncommon disease with different clinical and pathological features from those of other colon cancers. We aimed to investigate the clinical implications of expression of mucins in appendiceal carcinoma. METHODS: Expression profiles of MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC6, MUC16 and MUC17 in cancer tissue were examined by immunohistochemistry in 108 cases of surgically resected appendiceal carcinoma. RESULTS: The following relationships of mucins with clinicopathologic factors were identified: MUC1 with positive lymphatic invasion (p = 0.036); MUC2 with histological type (mucinous carcinoma, p<0.001), superficial invasion depth (p = 0.007), negative venous invasion (p = 0.003), and curative resection (p = 0.019); MUC3 with non-curative resection (p = 0.017); MUC5AC with histological type (mucinous carcinoma, p = 0.002), negative lymphatic invasion (p = 0.021), and negative venous invasion (p = 0.022); and MUC16 with positive lymph node metastasis (p = 0.035), positive venous invasion (p<0.05), and non-curative resection (p = 0.035). A poor prognosis was related to positive lymph node metastasis (p = 0.04), positive lymphatic invasion (p = 0.02), positive venous invasion (p<0.001), non-curative resection (p<0.001), and positive expression of MUC3 (p = 0.004). In multivariate analysis, positive venous invasion (HR: 6.93, 95% CI: 1.93–24.96, p = 0.003), non-curative resection (HR: 10.19, 95% CI: 3.05–34.07, p<0.001) and positive MUC3 expression (HR: 3.37, 95% CI: 1.13–10.03, p = 0.03) were identified as significant independent prognostic factors in patients with appendiceal carcinoma. CONCLUSIONS: Expression of MUC3 in appendiceal carcinoma is an independent factor for poor prognosis and a useful predictor of outcome in patients with appendiceal carcinoma after surgery.
format Online
Article
Text
id pubmed-4281150
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42811502015-01-07 A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor Shibahara, Hiroaki Higashi, Michiyo Yokoyama, Seiya Rousseau, Karine Kitazono, Iwao Osako, Masahiko Shirahama, Hiroshi Tashiro, Yukie Kurumiya, Yasuhiro Narita, Michihiko Kuze, Shingo Hasagawa, Hiroshi Kato, Takehito Kubota, Hitoshi Suzuki, Hideaki Arai, Toshiyuki Sakai, Yu Yuasa, Norihiro Fujino, Masahiko Kondo, Shinji Okamoto, Yoshichika Yamamoto, Tatsuyoshi Hiromatsu, Takashi Sasaki, Eiji Shirai, Kazuhisa Kawai, Satoru Hattori, Koutarou Tsuji, Hideki Okochi, Osamu Sakamoto, Masaki Kondo, Akinobu Konishi, Naomi Batra, Surinder K. Yonezawa, Suguru PLoS One Research Article BACKGROUND: Mucins are implicated in survival in various cancers, but there have been no report addressed on survival in appendiceal carcinoma, an uncommon disease with different clinical and pathological features from those of other colon cancers. We aimed to investigate the clinical implications of expression of mucins in appendiceal carcinoma. METHODS: Expression profiles of MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC6, MUC16 and MUC17 in cancer tissue were examined by immunohistochemistry in 108 cases of surgically resected appendiceal carcinoma. RESULTS: The following relationships of mucins with clinicopathologic factors were identified: MUC1 with positive lymphatic invasion (p = 0.036); MUC2 with histological type (mucinous carcinoma, p<0.001), superficial invasion depth (p = 0.007), negative venous invasion (p = 0.003), and curative resection (p = 0.019); MUC3 with non-curative resection (p = 0.017); MUC5AC with histological type (mucinous carcinoma, p = 0.002), negative lymphatic invasion (p = 0.021), and negative venous invasion (p = 0.022); and MUC16 with positive lymph node metastasis (p = 0.035), positive venous invasion (p<0.05), and non-curative resection (p = 0.035). A poor prognosis was related to positive lymph node metastasis (p = 0.04), positive lymphatic invasion (p = 0.02), positive venous invasion (p<0.001), non-curative resection (p<0.001), and positive expression of MUC3 (p = 0.004). In multivariate analysis, positive venous invasion (HR: 6.93, 95% CI: 1.93–24.96, p = 0.003), non-curative resection (HR: 10.19, 95% CI: 3.05–34.07, p<0.001) and positive MUC3 expression (HR: 3.37, 95% CI: 1.13–10.03, p = 0.03) were identified as significant independent prognostic factors in patients with appendiceal carcinoma. CONCLUSIONS: Expression of MUC3 in appendiceal carcinoma is an independent factor for poor prognosis and a useful predictor of outcome in patients with appendiceal carcinoma after surgery. Public Library of Science 2014-12-31 /pmc/articles/PMC4281150/ /pubmed/25551773 http://dx.doi.org/10.1371/journal.pone.0115613 Text en © 2014 Shibahara et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Shibahara, Hiroaki
Higashi, Michiyo
Yokoyama, Seiya
Rousseau, Karine
Kitazono, Iwao
Osako, Masahiko
Shirahama, Hiroshi
Tashiro, Yukie
Kurumiya, Yasuhiro
Narita, Michihiko
Kuze, Shingo
Hasagawa, Hiroshi
Kato, Takehito
Kubota, Hitoshi
Suzuki, Hideaki
Arai, Toshiyuki
Sakai, Yu
Yuasa, Norihiro
Fujino, Masahiko
Kondo, Shinji
Okamoto, Yoshichika
Yamamoto, Tatsuyoshi
Hiromatsu, Takashi
Sasaki, Eiji
Shirai, Kazuhisa
Kawai, Satoru
Hattori, Koutarou
Tsuji, Hideki
Okochi, Osamu
Sakamoto, Masaki
Kondo, Akinobu
Konishi, Naomi
Batra, Surinder K.
Yonezawa, Suguru
A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor
title A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor
title_full A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor
title_fullStr A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor
title_full_unstemmed A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor
title_short A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor
title_sort comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: muc3 is a novel prognostic factor
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281150/
https://www.ncbi.nlm.nih.gov/pubmed/25551773
http://dx.doi.org/10.1371/journal.pone.0115613
work_keys_str_mv AT shibaharahiroaki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT higashimichiyo acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT yokoyamaseiya acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT rousseaukarine acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kitazonoiwao acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT osakomasahiko acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT shirahamahiroshi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT tashiroyukie acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kurumiyayasuhiro acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT naritamichihiko acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kuzeshingo acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT hasagawahiroshi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT katotakehito acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kubotahitoshi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT suzukihideaki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT araitoshiyuki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT sakaiyu acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT yuasanorihiro acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT fujinomasahiko acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kondoshinji acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT okamotoyoshichika acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT yamamototatsuyoshi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT hiromatsutakashi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT sasakieiji acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT shiraikazuhisa acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kawaisatoru acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT hattorikoutarou acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT tsujihideki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT okochiosamu acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT sakamotomasaki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kondoakinobu acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT konishinaomi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT batrasurinderk acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT yonezawasuguru acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT shibaharahiroaki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT higashimichiyo comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT yokoyamaseiya comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT rousseaukarine comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kitazonoiwao comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT osakomasahiko comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT shirahamahiroshi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT tashiroyukie comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kurumiyayasuhiro comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT naritamichihiko comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kuzeshingo comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT hasagawahiroshi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT katotakehito comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kubotahitoshi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT suzukihideaki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT araitoshiyuki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT sakaiyu comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT yuasanorihiro comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT fujinomasahiko comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kondoshinji comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT okamotoyoshichika comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT yamamototatsuyoshi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT hiromatsutakashi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT sasakieiji comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT shiraikazuhisa comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kawaisatoru comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT hattorikoutarou comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT tsujihideki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT okochiosamu comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT sakamotomasaki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT kondoakinobu comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT konishinaomi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT batrasurinderk comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor
AT yonezawasuguru comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor